Advertisement
<< Back To Article
HIV, Hep C Drug Development Pipeline is 'Robust,' Says Report

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

1 Comments

George Medeiros

I was so exited when I heard the new protease inhibitors for Hep C had been approved by the FDA, not so excited about the price, and totally let down when my doctor told me since I was already on a protease inhibitor for HIV, I couldn't be on a protease inhibitor for Hep C at the same time- here are no trials for dual infection. This was only for patients with Hep C only. The bottom fell out of my world.

July 16, 2011 Ft Lauderdale, FL

Advertisement

Hot topics


POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.